- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02100020
Implementing Physical Activity Guidelines for Adults With MS
A Community-based Randomized Controlled Trial Testing Implementation of the New Canadian Physical Activity Guidelines for Adults With Multiple Sclerosis.
The proposed project will evaluate two methods of implementation of the new Physical Activity Guidelines (PAGs) for Adults with Multiple Sclerosis (MS) living in two Ontario communities. The investigators will also determine if following the PAGs will improve aspects of fitness, function, quality of life and risk for cardiometabolic disease in this population. The investigators hypothesize that adherence to the PAGs will be higher in people who have been referred directly to a community-based exercise program, and that this greater adherence to physical activity will be associated with greater improvements in fitness, function and quality of life.
This randomized controlled trial will provide important information on how best to implement physical activity recommendations within the community setting; this information will be translated to key stakeholders during the final stages of the project.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4K1
- McMaster University, Physical Activity Centre for Excellence
-
Kingston, Ontario, Canada, K7L 3N6
- Queens University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of MS with mild-moderate disability (EDSS 1-7)
- Aged 18-60
- Medical clearance to participate in physical activity
Exclusion Criteria:
- current participation in regular physical activity (at least twice-weekly)
- other serious medical condition that might impair ability to participate in strength or aerobic exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Direct Referral to Physical Activity
The REF group will be referred to a centre-based community exercise program in their respective community (either the MacWheelers or Revved Up) by a clinical neurologist where they will be prescribed exercise based on the PAGs for adults with MS, and according to their individual capabilities.
|
Participants randomized to the Direct Referral to Physical Activity Arm will be provided with a referral to a physical activity program in their community and will be closely monitored in this program for 16 wks.
|
|
No Intervention: Control
The CON group will be provided with a print copy of the PAGs and a link to an online resource for physical activity information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to the Physical Activity Guidelines
Time Frame: 3 years
|
Adherence to the physical activity guidelines will be analyzed by having participants fill in a weekly physical activity log that will be sent to them by email.
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Fitness
Time Frame: At baseline and after the 16 week intervention
|
Peak oxygen uptake, maximum muscle strength, bodyweight
|
At baseline and after the 16 week intervention
|
|
Perceived Quality of Life
Time Frame: At baseline and after the 16 week intervention
|
Multiple Sclerosis Quality of Life (MSQoL) scale
|
At baseline and after the 16 week intervention
|
|
Fatigue
Time Frame: At baseline and after the 16 week intervention
|
Multiple Sclerosis Fatigue Impact Scale (MSFIS)
|
At baseline and after the 16 week intervention
|
|
Mobility
Time Frame: At baseline and after the 16 week intervention
|
25ft walk test
|
At baseline and after the 16 week intervention
|
|
Blood markers of cardiovascular disease risk
Time Frame: At baseline and after the 16 week intervention
|
blood lipid panel, HbA1c, fasting glucose
|
At baseline and after the 16 week intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Audrey L Hicks, Ph.D., McMaster University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSProject2001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Direct Referral to physical activity
-
University of California, BerkeleyCompleted
-
University of Erlangen-NürnbergCompletedNon-Communicable Chronic DiseasesGermany
-
Paula WatsonRadboud University Medical Center; University of Bath; University of Liverpool; University of Gloucestershire and other collaboratorsCompletedDepression | Cardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Cancer | Physical Activity | Metabolic Syndrome | Anxiety | Cardiovascular Risk Factor | Musculoskeletal InjuryUnited Kingdom
-
HaEmek Medical Center, IsraelRambam Health Care Campus; Technion, Israel Institute of TechnologyNot yet recruiting
-
Copenhagen University Hospital, HvidovreUniversity of Copenhagen; Sygekassernes Helsefond; The Danish Rheumatism Association and other collaboratorsCompletedOsteoarthritis, KneeDenmark
-
Hebrew SeniorLifeCompleted
-
Laval UniversityCanadian Institutes of Health Research (CIHR)Completed
-
Radboud University Medical CenterMichael J. Fox Foundation for Parkinson's Research; ZonMw: The Netherlands...CompletedParkinson's DiseaseNetherlands
-
Centre of Postgraduate Medical EducationCompletedPulmonary Arterial Hypertension | Physical InactivityPoland
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPhysical Activity | Weight Loss | Health-related Quality of LifeUnited States